Carles Canto
EPFL Innovation Park
Lausanne, VD 1015, Switzerland
Lausanne, VD 1015, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
NAD+ precursor supplementation in human ageing: clinical evidence and challenges.
Journal: Nature metabolism
Published: April 07, 2025
Emerging strategies, applications and challenges of targeting NAD+ in the clinic.
Journal: Nature aging
Published: August 27, 2024
Therapeutic potential of dihydronicotinamide riboside (NRH) on obesity and glucose intolerance in mice.
Journal: Nature communications
Published: August 20, 2024
Nicotinamide riboside kinases regulate skeletal muscle fiber-type specification and are rate-limiting for metabolic adaptations during regeneration.
Journal: Frontiers in cell and developmental biology
Published: September 20, 2022
Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure.
Journal: Molecular metabolism
Published: July 20, 2022
A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD+ metabolism.
Journal: Biosensors & bioelectronics
Published: June 28, 2022
Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD+ by Generating Dihydronicotinamide Riboside.
Journal: Nutrients
Published: June 15, 2022
Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations.
Journal: Cellular and molecular life sciences : CMLS
Published: March 31, 2022
A Method to Monitor the NAD+ Metabolome-From Mechanistic to Clinical Applications.
Journal: International journal of molecular sciences
Published: August 27, 2021
Last Updated: 09/26/2026